John A. Stalfort III
Director · Acumen Pharmaceuticals, Inc.
- 2024
- Jun 5, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John A. Stalfort III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul B. Manning - $17.51M in VRCA purchases and sales in the last 12 months
- Sukumar Nagendran - $5.33M in TSHA purchases and sales in the last 12 months
- Sean P. Nolan - $840K in TSHA purchases and sales in the last 12 months
- Jayson Rieger - $526K in VRCA purchases and sales in the last 12 months
- Kamran Alam - $493K in TSHA purchases and sales in the last 12 months
- Derek M. Meisner - $105K in ABOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John A. Stalfort III?
John A. Stalfort III is a corporate insider, tracked as Director of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John A. Stalfort III last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2024.
Has John A. Stalfort III been buying or selling stock?
Recorded transactions: 3 open-market purchases and 0 open-market sales across all tracked filings.
